Most health professionals know that iron overload can, after many years, lead to multiple organ failures, if not diagnosed and treated. Yet the messaging around over-consuming iron is often missed.
Medigrowth, a fully licensed Australian medicinal cannabis biotech, has announced plans to build a Centre of Excellence in Geelong in partnership with Deakin University.
Qld researchers are trialling a new vaccine that could deliver single dose protection and reduce hospitalisation rates of premature babies after discharge.
A new class of anti-inflammatory medication developed in Australia is being prepared for regulatory approval.
The specialist breast surgeon will join FECRI's breast cancer research group as a Collaborating Clinician in metropolitan Melbourne.
Researchers have developed a disease-specific measure designed to capture and assess the wide-ranging issues that affect patients with locally recurrent rectal cancer.
Patient navigation is strongly linked to increased and successful rates of screening, earlier medical diagnosis and cancer outcomes worldwide, according to a new study.
The tool identifies sperm, then leaves the embryologist to decide whether it is really present and if it is viable enough for Intracytoplasmic Sperm Injection.
Eleven recommendations on when, how and in what situation it may be appropriate for clinicians to reduce opioid use by placing the patient at the centre of the equation have been released.
WHO has published its first global research agenda for the world's scientists to address the most urgent human health priorities to combat antimicrobial resistance (AMR).
A recent study has identified Western Australia and parts of the Northern Territory and Tasmania as asthma 'hot spots', recording the highest numbers of people with difficult-to-treat asthma in Australia.
A trial by the Malaghan Institute's Hookworm Therapy team suggests so.
While tranexamic acid is commonly used to limit bleeding during surgery, its usefulness in emergency settings to treat life-threatening bleeding has been questioned.
The 'Make a Difference' campaign aims to improve the lives of those affected by IAD and promote optimal management practices.
C-section babies' microbiota are dominated by bacteria found on the mother's skin, in breastmilk and in the environment.